We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Review of Palliative Radiotherapy in the Management of Advanced Head and Neck Cancer

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00280891
First Posted: January 24, 2006
Last Update Posted: January 28, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
AHS Cancer Control Alberta
  Purpose
To describe the charactersitics of patients with advanced head and neck cancer treated with palliative intent and determine outcome in terms of symptom control and toxicity

Condition
Head and Neck Cancer

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: Review of Palliative Radiotherapy in the Management of Advanced Head and Neck Cancer

Resource links provided by NLM:


Further study details as provided by AHS Cancer Control Alberta:

Estimated Enrollment: 100
Study Start Date: January 2006
Study Completion Date: June 2006
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • squamous cell carcinoma of the head and neck, primary treatment given with palliative intent

Exclusion Criteria:

  • radical treatment, palliative treatment following local recurrence, adenocarcinoma, salivary gland carcinoma or melanoma
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00280891


Locations
Canada, Alberta
Tom Baker Cancer Centre
Calgary, Alberta, Canada, T2N 4N2
Sponsors and Collaborators
Alberta Health Services
Investigators
Principal Investigator: Harold Lau, MD Alberta Cancerboard
  More Information

ClinicalTrials.gov Identifier: NCT00280891     History of Changes
Other Study ID Numbers: 18882
First Submitted: January 20, 2006
First Posted: January 24, 2006
Last Update Posted: January 28, 2013
Last Verified: July 2006

Keywords provided by AHS Cancer Control Alberta:
head and neck
cancer
palliation
radiotherapy

Additional relevant MeSH terms:
Head and Neck Neoplasms
Neoplasms by Site
Neoplasms


To Top